Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$30.9 - $33.55 $933,828 - $1.01 Million
30,221 New
30,221 $952,000
Q2 2022

Aug 15, 2022

SELL
$23.75 - $31.69 $416,242 - $555,398
-17,526 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$19.97 - $26.94 $349,994 - $472,150
17,526 New
17,526 $455,000
Q3 2021

Nov 15, 2021

SELL
$17.35 - $22.5 $1.73 Million - $2.24 Million
-99,556 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$18.01 - $28.32 $806,541 - $1.27 Million
-44,783 Reduced 31.03%
99,556 $2.21 Million
Q1 2021

May 17, 2021

SELL
$19.76 - $29.89 $5.06 Million - $7.66 Million
-256,130 Reduced 63.96%
144,339 $3.79 Million
Q4 2020

Feb 12, 2021

BUY
$15.73 - $21.66 $5.87 Million - $8.09 Million
373,369 Added 1377.75%
400,469 $7.49 Million
Q3 2020

Nov 16, 2020

BUY
$13.54 - $26.41 $366,934 - $715,711
27,100 New
27,100 $460,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.